These data show the novel finding that the 2-oxindole fluorinated derivative compound 8c is effective at inhibiting the growth of prostate tumor xenografts and activating AMPK in vivo and accordingly has a great potential as a candidate to treat prostate cancer. Here, PRKAA2 is linked to prostate carcinoma.